Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sugar water vs. steroids: a new battle against back pain

NCT ID NCT07757321

Disease control Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether a simple sugar solution (10% dextrose) can match a steroid (triamcinolone) in easing pain from a herniated disc in the lower back. Adults with chronic back or leg pain for at least 3 months will receive one of the two injections right after a standard nerve treatment called pulsed radiofrequency. The study tracks pain levels, disability, and nerve-related pain over 14 days to see if the sugar solution is a viable, steroid-free alternative.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
10% dextrose injection or triamcinolone injection, given as an add-on to pulsed radiofrequency treatment
What this could lead to
If dextrose works as well as steroids, it could offer a safer, non-steroid option to ease chronic back pain from a herniated disc.
What could go wrong
This is a small, early-stage trial with a short 14-day follow-up, so results may not be lasting or apply broadly. Dextrose may not match the steroid's pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Dec 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-65 years. * Diagnosed with lumbar herniated nucleus pulposus (HNP) confirmed by magnetic resonance imaging (MRI). * Chronic low back pain and/or radicular pain for at least 3 months. * Numeric Rating Scale (NRS) pain score ≥4. * No indication for surgical intervention. * Eligible for pulsed radiofrequency of the dorsal root ganglion with transforaminal epidural injection. * Able to understand the study procedures and provide written informed consent. Exclusion Criteria: * Previous lumbar spine surgery. * Progressive neurological deficits or cauda equina syndrome. * Indication for immediate spinal surgery. * Known hypersensitivity to dextrose, triamcinolone, local anesthetics, or study medications. * Coagulation disorders or current anticoagulant therapy that cannot be safely discontinued. * Local or systemic infection. * Pregnancy or breastfeeding. * Uncontrolled diabetes mellitus or other severe uncontrolled systemic disease. * Severe psychiatric illness or cognitive impairment affecting study participation. * Participation in another interventional clinical trial. * Inability or unwillingness to complete the scheduled follow-up assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Herniated nucleus pulposus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Herniated nucleus pulposus PRF

Contacts and locations

Locations

  • RSUD Tarakan

    Jakarta, DKI Jakarta, 10150, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.